In addition, we reported that lysyl oxidase-like-1 (LOXL1) was related to NK cell therapeutics in the CCl4-induced liver cirrhosis mouse model (Figure 7, Table 2). This evidence concerns the gene LOXL1 and cirrhosis of liver.